Abstract | PURPOSE: SETTING: Moorfields Eye Hospital Uveitis Service, London, United Kingdom. METHODS: RESULTS: Median visual acuity 1 day after surgery was 20/40 (range 20/20 to counting fingers). At final follow-up (mean 25.2 months; range 7 to 41 months), 17 eyes (89.5%) eyes achieved visual acuity of 20/40 or better; 2 eyes failed to achieve a final visual acuity of 20/40 or better, 1 as a result of optic atrophy and the other as a result of macular edema. No patient lost acuity and no eye developed macular edema within 4 months of surgery. Intraocular pressure elevation occurred after surgery in 3 eyes; all were controlled by topical medication that was discontinued after 3 months. One patient developed severe intraocular inflammation after surgery that resolved with intensive topical corticosteroid therapy within 1 week. CONCLUSIONS:
|
Authors | Narciss Okhravi, Ainsley Morris, Howe Sen Kok, Victor Menezo, Jonathan G F Dowler, Phillip G Hykin, Sue Lightman |
Journal | Journal of cataract and refractive surgery
(J Cataract Refract Surg)
Vol. 33
Issue 7
Pg. 1278-83
(Jul 2007)
ISSN: 0886-3350 [Print] United States |
PMID | 17586387
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Glucocorticoids
- Triamcinolone Acetonide
|
Topics |
- Adult
- Aged
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Injections
- Intraocular Pressure
- Intraoperative Care
- Lens Implantation, Intraocular
- Macular Edema
(prevention & control)
- Male
- Middle Aged
- Phacoemulsification
- Pilot Projects
- Prospective Studies
- Treatment Outcome
- Triamcinolone Acetonide
(therapeutic use)
- Uveitis, Posterior
(drug therapy)
- Visual Acuity
- Vitreous Body
|